Yu Jeffrey

SEC source: 0001493152-26-046908 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 896,840

F1 · kind: On October 9, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-042642 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,923,267

F1 · kind: On September 10, 2026, the issuer entered into a subscription agreement with the reporting person for a $90,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-029878 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,780,410

F1 · kind: On June 23, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

SEC source: 0001493152-26-028988 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,621,680

F1 · kind: On June 16, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

SEC source: 0001493152-26-018861 · ownership.xml · nonDerivative · entry 2

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,449,266

F2 · kind: Represents shares issued in lieu of prior cash compensation owed to the reporting person. The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the issuance date.

SEC source: 0001493152-26-018861 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,229,837

F1 · kind: On April 1, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer. The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 22

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,326,223

F21 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 21

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,281,223

F20 · shares: Represents restricted stock units ("RSUs") granted under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") as employment compensation. RSUs vest as to one-third (1/3) of the RSUs on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting thereafter in equal quarterly installments on the last day of each fiscal quarter over the subsequent two (2) years, provided that the recipient remains in continuous service through each vesting date.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 20

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,081,223

F19 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.04, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 19

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,079,973

F18 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.01 to $1.05, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 18

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,062,773

F17 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.91 to $0.96, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 17

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,057,073

F16 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 16

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,056,673

F15 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.88 to $0.92, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 15

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,055,423

F14 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.94, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 14

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,054,723

F13 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.84 to $0.90, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 13

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,052,623

F12 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.84 to $0.92, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 12

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,040,813

F11 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.77 to $0.86, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 11

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,029,143

F10 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.83 to $0.88, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 10

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,004,824

F9 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.79 to $0.85, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 9

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,993,934

F8 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.78 to $0.81, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 8

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,976,934

F7 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.68 to $0.72, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 7

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,955,560

F6 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.66 to $0.79, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 6

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,782,210

F5 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.74 to $0.75, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 5

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,768,910

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 4

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,753,910

F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.76 to $0.79, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 3

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,737,410

F3 · shares: On June 20, 2025, the issuer entered into a subscription agreement with the reporting person, pursuant which the issuer agreed to sell 1,666,666 shares of common stock to the reporting person at a purchase price of $0.42 per share, totaling $700,000 in gross proceeds to the issuer.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 2

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,070,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: On June 19, 2025, the issuer entered into an agreement with the reporting person to convert an aggregate of approximately $1.3 million of outstanding principal and accrued interest under certain shareholder loans and business combination extension loans.

SEC source: 0001493152-25-025279 · ownership.xml · derivative · entry 24

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479,270 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance.

F1 · price: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance.

F1 · derivative.exercise_date: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance.

F1 · derivative.expiration_date: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance.

F8 · derivative.underlying_shares: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.78 to $0.81, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,242,465

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance.

SEC source: 0001493152-25-025279 · ownership.xml · derivative · entry 25

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,946

Underlying: Common Stock · 5,946 shares

Expires 2028-11-07

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 22

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,763,195

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 21

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,763,095

F12 · shares: Represents restricted stock units ("RSUs") issued in lieu of cash compensation, which RSUs vested in full on July 1, 2025. Each RSU represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 20

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,532,326

F11 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.62 to $0.66, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 19

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,530,726

F10 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.65 to $0.71, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 18

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,926

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 17

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,826

F9 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.36 to $1.46, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 16

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,812

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 15

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,802

F8 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.33 to $1.37, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 14

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,789

F7 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.25, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 13

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,527,552

F6 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.16, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 12

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,526,639

F5 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.50 to $0.55, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 11

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,525,436

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 10

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,525,331

F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.66 to $0.69, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 9

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,525,225

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.61 to $0.67, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 8

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,525,011

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.59 to $0.61, inclusive.

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 7

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,524,661

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 6

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,524,561

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 5

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,524,461

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 4

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,524,361

SEC source: 0001493152-25-025278 · ownership.xml · nonDerivative · entry 3

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,524,345